Trexquant Investment LP Caribou Biosciences, Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$3.58 - $6.25 $726,711 - $1.27 Million	-202,992 Reduced 94.79%	11,152 $63,000
Q3 2023 Nov 13, 2023	BUY	$4.08 - $8.14 $511,130 - $1.02 Million	125,277 Added 140.97%	214,144 $1.02 Million
Q2 2023 Aug 11, 2023	BUY	$4.04 - $5.47 $359,022 - $486,102	88,867 New	88,867 $377,000
Q2 2022 Aug 11, 2022	SELL	$5.1 - $9.74 $71,303 - $136,174	-13,981 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.42 - $15.32 $117,720 - $214,188	13,981 New	13,981 $128,000

135

52.6M

148K

70.7K

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $123M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.